Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Fellowship - PA: Biomedical / Clinical HIV/AIDS Research

Sunnybrook Research Institute (Toronto, Ontario)

$135,000.00

Generation of HIV resistant T cell progenitors from human induced pluripotent stem cells

EF 2011-12

Résumé
The human immunodeficiency virus (HIV) infects immune system cells and either kills them or impairs their function, and can lead to acquired immune deficiency syndrome (AIDS). An impaired immune system is unable to surmount a proper immune response against infections and diseases. HIV-inflicted people that receive uninfected bone marrow progenitor cells are very likely to have these cells infected with HIV as well. Furthermore, availability of compatible progenitor cells is very limited. To address these problems we propose to use in vitro sources of stem cells, as well as a special type of stem cell that can be obtained by reprogramming adult cells such as skin cells. We have already been successful in generating immune system cells from these sources, providing a potentially unlimited supply of cells. These cells can be readily modified in order to acquire resistance to HIV infections, and their efficacy can be assessed in the laboratory. Our work would provide a novel, patient specific approach for developing patient-specific prevention and treatment to HIV infection.
Programme
Fellowship - PA: Biomedical / Clinical HIV/AIDS Research
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
243118
Name
Brauer Patrick M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Generation of HIV resistant T cell progenitors from human induced pluripotent stem cells
Programtype2
Fellowship Programs
Orgnameinp2
Sunnybrook Research Institute (Toronto, Ontario)
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
Fellowship - PA: Biomedical / Clinical HIV/AIDS Research
Keyworddelim
Acquired Immune Deficiency Disease (Aids); Hematopoietic Stem Cell (Hsc); Human Immunodeficiency Virus (Hiv); Induced Pluripotent Stem Cell (Ipsc)
Abstract
The human immunodeficiency virus (HIV) infects immune system cells and either kills them or impairs their function, and can lead to acquired immune deficiency syndrome (AIDS). An impaired immune system is unable to surmount a proper immune response against infections and diseases. HIV-inflicted people that receive uninfected bone marrow progenitor cells are very likely to have these cells infected with HIV as well. Furthermore, availability of compatible progenitor cells is very limited. To address these problems we propose to use in vitro sources of stem cells, as well as a special type of stem cell that can be obtained by reprogramming adult cells such as skin cells. We have already been successful in generating immune system cells from these sources, providing a potentially unlimited supply of cells. These cells can be readily modified in order to acquire resistance to HIV infections, and their efficacy can be assessed in the laboratory. Our work would provide a novel, patient specific approach for developing patient-specific prevention and treatment to HIV infection.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Brauer, Patrick M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~